These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23704976)
1. Susceptibility of hamsters to Clostridium difficile isolates of differing toxinotype. Buckley AM; Spencer J; Maclellan LM; Candlish D; Irvine JJ; Douce GR PLoS One; 2013; 8(5):e64121. PubMed ID: 23704976 [TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744 [TBL] [Abstract][Full Text] [Related]
3. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928 [TBL] [Abstract][Full Text] [Related]
4. An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile. Miezeiewski M; Schnaufer T; Muravsky M; Wang S; Caro-Aguilar I; Secore S; Thiriot DS; Hsu C; Rogers I; DeSantis T; Kuczynski J; Probst AJ; Chehoud C; Steger R; Warrington J; Bodmer JL; Heinrichs JH ISME J; 2015 Feb; 9(2):321-32. PubMed ID: 25036923 [TBL] [Abstract][Full Text] [Related]
5. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Nagaro KJ; Phillips ST; Cheknis AK; Sambol SP; Zukowski WE; Johnson S; Gerding DN Antimicrob Agents Chemother; 2013 Nov; 57(11):5266-70. PubMed ID: 23939887 [TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection in an Iranian hospital. Jalali M; Khorvash F; Warriner K; Weese JS BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392 [TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models. Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616 [TBL] [Abstract][Full Text] [Related]
8. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model. Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803 [TBL] [Abstract][Full Text] [Related]
9. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran. Doosti A; Mokhtari-Farsani A Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619 [TBL] [Abstract][Full Text] [Related]
10. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model. Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010. Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742 [TBL] [Abstract][Full Text] [Related]
12. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348 [TBL] [Abstract][Full Text] [Related]
14. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection. Shin BM; Kuak EY; Lee EJ; Songer JG J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481 [TBL] [Abstract][Full Text] [Related]
15. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255 [TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027. Wieczorkiewicz JT; Lopansri BK; Cheknis A; Osmolski JR; Hecht DW; Gerding DN; Johnson S Antimicrob Agents Chemother; 2016 Jan; 60(1):418-23. PubMed ID: 26525793 [TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. Kim J; Pai H; Seo MR; Kang JO BMC Infect Dis; 2012 May; 12():109. PubMed ID: 22571633 [TBL] [Abstract][Full Text] [Related]
18. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters. Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461 [TBL] [Abstract][Full Text] [Related]
19. A possible role for Clostridium difficile in the etiology of calf enteritis. Hammitt MC; Bueschel DM; Keel MK; Glock RD; Cuneo P; DeYoung DW; Reggiardo C; Trinh HT; Songer JG Vet Microbiol; 2008 Mar; 127(3-4):343-52. PubMed ID: 17964088 [TBL] [Abstract][Full Text] [Related]